These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7712723)

  • 21. Serum angiotensin-converting enzyme is not an indicator of dialyzer membrane biocompatibility.
    Docci D; Turci F; Baldrati L; Delvecchio C
    Nephron; 1988; 48(4):335. PubMed ID: 2834657
    [No Abstract]   [Full Text] [Related]  

  • 22. Protein adsorption on dialyzer membranes influences their biocompatibility properties.
    Kuwahara T; Markert M; Wauters JP
    Contrib Nephrol; 1989; 74():52-7. PubMed ID: 2562019
    [No Abstract]   [Full Text] [Related]  

  • 23. Biocompatible dialysis membranes: do they matter?
    Kooman JP; Leunissen KM
    Neth J Med; 1998 May; 52(5):156-9. PubMed ID: 9652153
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemical modification of cellulosic membranes and their blood compatibility.
    Paul D; Malsch G; Bossin E; Wiese F; Thomaneck U; Brown GS; Werner H; Falkenhagen D
    Artif Organs; 1990 Apr; 14(2):122-5. PubMed ID: 2350257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Does the biocompatibility of the hemodialysis membrane influence the prognosis of acute renal insufficiency?].
    Tielemans C; Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL
    Nephrologie; 1998; 19(2):89-91. PubMed ID: 9592779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dialysis fluid and water: their roles in biocompatibility.
    Berland Y; Brunet P; Ragon A; Reynier JP
    Nephrol Dial Transplant; 1995; 10 Suppl 10():45-7. PubMed ID: 8825432
    [No Abstract]   [Full Text] [Related]  

  • 27. Biocompatibility aspects of chronic hemodialysis and their clinical relevance.
    Wauters JP
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S19-23. PubMed ID: 8608656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility?
    Ward RA
    Nephrol Dial Transplant; 1995; 10 Suppl 10():12-17. PubMed ID: 8825427
    [No Abstract]   [Full Text] [Related]  

  • 29. [The influence of dialysis dose and the dialyzer membrane biocompatibility on the outcome of acute renal failure].
    Kes P; Sefer S
    Lijec Vjesn; 1999; 121(9-10):326-8. PubMed ID: 19662688
    [No Abstract]   [Full Text] [Related]  

  • 30. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialysis membranes: clinical effects.
    Boulton-Jones M
    Lancet; 1994 Aug; 344(8922):559. PubMed ID: 7914953
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of modern microscopic techniques for examining dialysis membrane properties].
    Kowal A; Nowak S; Sułowicz W; Pietrzyk JA; Krawentek L; Drozdz M; Nowogrodzka-Zagórska M; Bal W
    Przegl Lek; 2000; 57(12):702-6. PubMed ID: 11398590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the dialysis membrane in acute renal failure.
    Kaplan AA; Paganini EP; Bosch JP
    N Engl J Med; 1995 Apr; 332(14):961-2. PubMed ID: 7877664
    [No Abstract]   [Full Text] [Related]  

  • 35. Adherence of blood cells to dialyzer membranes as a measure of biocompatibility.
    Kjellstrand P; Okmark P; Odselius R; Thysell H; Riede G; Holmquist B
    Int J Artif Organs; 1991 Nov; 14(11):698-702. PubMed ID: 1757156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatible dialysis membranes do not reduce plasma leptin levels.
    Wright MJ; Woodrow G; Young G; Brownjohn AM; Turney JH
    Nephrol Dial Transplant; 2000 Jun; 15(6):925-6. PubMed ID: 10831667
    [No Abstract]   [Full Text] [Related]  

  • 37. Selection guidelines for high-performance membrane.
    Sanaka T; Koremoto M
    Contrib Nephrol; 2011; 173():30-35. PubMed ID: 21865773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement activation as index of haemodialysis membrane biocompatibility: the choice of methods and assays.
    Cheung AK
    Nephrol Dial Transplant; 1994; 9 Suppl 2():96-103. PubMed ID: 8065623
    [No Abstract]   [Full Text] [Related]  

  • 39. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Krieter DH; Lemke HD; Wanner C
    Nephrol Dial Transplant; 2006 Feb; 21(2):546; author reply 546. PubMed ID: 16249195
    [No Abstract]   [Full Text] [Related]  

  • 40. Biocompatibility: methodology and evaluation.
    Falkenhagen D; Mitzner S; Stange J; Klinkmann H
    Contrib Nephrol; 1993; 103():34-54. PubMed ID: 8354062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.